GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Indo US Bio-Tech Ltd (NSE:INDOUS) » Definitions » Revenue

Indo US Bio-Tech (NSE:INDOUS) Revenue : ₹615.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Indo US Bio-Tech Revenue?

Indo US Bio-Tech's revenue for the three months ended in Dec. 2024 was ₹235.6 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was ₹615.0 Mil. Indo US Bio-Tech's Revenue per Share for the three months ended in Dec. 2024 was ₹11.75. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ₹30.56.

Good Sign:

Indo US Bio-Tech Ltd has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Indo US Bio-Tech was 19.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 9.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 14.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 16.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 12 years, Indo US Bio-Tech's highest 3-Year average Revenue per Share Growth Rate was 32.90% per year. The lowest was -1.30% per year. And the median was 17.70% per year.


Indo US Bio-Tech Revenue Historical Data

The historical data trend for Indo US Bio-Tech's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo US Bio-Tech Revenue Chart

Indo US Bio-Tech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 397.61 401.10 500.59 617.45 728.36

Indo US Bio-Tech Quarterly Data
Mar17 Oct17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 158.14 221.14 157.66 221.73 235.64

Competitive Comparison of Indo US Bio-Tech's Revenue

For the Agricultural Inputs subindustry, Indo US Bio-Tech's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indo US Bio-Tech's Revenue Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's Revenue distribution charts can be found below:

* The bar in red indicates where Indo US Bio-Tech's Revenue falls into.


;
;

Indo US Bio-Tech Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹615.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Indo US Bio-Tech  (NSE:INDOUS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Indo US Bio-Tech Revenue Related Terms

Thank you for viewing the detailed overview of Indo US Bio-Tech's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Indo US Bio-Tech Business Description

Traded in Other Exchanges
Address
Satadhar Char Rasta, Sola Road, 309, Shanti Mall, Opposite Navrang Tower, Ahmedabad, GJ, IND, 380061
Indo US Bio-Tech Ltd is engaged in the trading of agricultural seeds. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of agriculture crops. The company's product categories include vegetables; cotton seeds; oilseeds; spices seeds; pulses seeds and cereals seeds. The company has two segments which include Agricultural Activities and Trading Activities out of which it generates the key revenue from the Agricultural Activities.

Indo US Bio-Tech Headlines

No Headlines